Paper32452829
Downregulation of miRNA-146a-5p promotes malignant transformation of mesenchymal stromal/stem cells by glioma stem-like cells.
Dai X and 14 others. Aging (Albany NY), 2020. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Downregulation of miRNA-146a-5p promotes malignant transformation of mesenchymal stromal/stem cells by glioma stem-like cells. Papers, record 32452829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32452829
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Downregulation of miRNA-146a-5p promotes malignant transformation of mesenchymal stromal/stem cells by glioma stem-like cells.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transformation, Neoplastic | Major topic |
| Glioma | Major topic |
| Mesenchymal Stem Cells | Major topic |
| MicroRNAs | Major topic |
| Adult | |
| Animals | |
| Biomarkers, Tumor | |
| Down-Regulation | |
| Female | |
| Humans | |
| Male | |
| Mice | |
| RNA, Small Interfering | |
| Tumor Microenvironment |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29280958 | Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/29280958 | PubMed |
| 2 | 27757723 | Identification of two distinct mesenchymal stromal cell populations in human malignant glioma. | J Neurooncol | 2017 | https://conductscience.org/library/papers/27757723 | PubMed |
| 3 | 21576471 | NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21576471 | PubMed |
| 4 | 29448000 | Bone marrow-derived fibrocytes promote stem cell-like properties of lung cancer cells. | Cancer Lett | 2018 | https://conductscience.org/library/papers/29448000 | PubMed |
| 5 | 25071842 | Role of microRNA-146a in normal and malignant hematopoietic stem cell function. | Front Genet | 2014 | https://conductscience.org/library/papers/25071842 | PubMed |
| 6 | 26694467 | Oncogenic MicroRNAs: Key Players in Malignant Transformation. | Cancers (Basel) | 2015 | https://conductscience.org/library/papers/26694467 | PubMed |
| 7 | 29993289 | Bone Marrow-Derived Mesenchymal Stem Cell-Mediated Dual-Gene Therapy for Glioblastoma. | Hum Gene Ther | 2019 | https://conductscience.org/library/papers/29993289 | PubMed |
| 8 | 22500732 | Horizontal transmission of malignancy by cell-cell fusion. | Expert Opin Biol Ther | 2012 | https://conductscience.org/library/papers/22500732 | PubMed |
| 9 | 25433944 | Correlation and malignant transformation of MSCs with the overexpression of SIL-R/GP130 under the tumor microenvironment. | Med Oncol | 2015 | https://conductscience.org/library/papers/25433944 | PubMed |
| 10 | 31061501 | The transcription factor CBFB suppresses breast cancer through orchestrating translation and transcription. | Nat Commun | 2019 | https://conductscience.org/library/papers/31061501 | PubMed |
| 11 | 27073479 | CD44 promotes the migration of bone marrow-derived mesenchymal stem cells toward glioma. | Oncol Lett | 2016 | https://conductscience.org/library/papers/27073479 | PubMed |
| 12 | 23215807 | A catalogue of glioblastoma and brain MicroRNAs identified by deep sequencing. | OMICS | 2012 | https://conductscience.org/library/papers/23215807 | PubMed |
| 13 | 31538956 | Down-regulation and clinical significance of miR-7-2-3p in papillary thyroid carcinoma with multiple detecting methods. | IET Syst Biol | 2019 | https://conductscience.org/library/papers/31538956 | PubMed |
| 14 | 23465882 | miRNA profiling of cancer. | Curr Opin Genet Dev | 2013 | https://conductscience.org/library/papers/23465882 | PubMed |
| 15 | 26049020 | Glioma initiating cells contribute to malignant transformation of host glial cells during tumor tissue remodeling via PDGF signaling. | Cancer Lett | 2015 | https://conductscience.org/library/papers/26049020 | PubMed |
| 16 | 22763674 | Rat bone marrow mesenchymal stem cells undergo malignant transformation via indirect co-cultured with tumour cells. | Cell Biochem Funct | 2012 | https://conductscience.org/library/papers/22763674 | PubMed |
| 17 | 23253700 | Incubation and application of transgenic green fluorescent nude mice in visualization studies on glioma tissue remodeling. | Chin Med J (Engl) | 2012 | https://conductscience.org/library/papers/23253700 | PubMed |
| 18 | 30143053 | Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas. | Stem Cell Res Ther | 2018 | https://conductscience.org/library/papers/30143053 | PubMed |
| 19 | 25906746 | MicroRNA-146a modulates B-cell oncogenesis by regulating Egr1. | Oncotarget | 2015 | https://conductscience.org/library/papers/25906746 | PubMed |
| 20 | 31189920 | The long non-coding RNA SNHG1 promotes glioma progression by competitively binding to miR-194 to regulate PHLDA1 expression. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31189920 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42023823 | Phaeochromocytomas and paragangliomas harbour tumour-initiating SOX2+ stem cells. | Endocr Relat Cancer | 2026 | https://conductscience.org/library/papers/42023823 | PubMed |
| 41511332 | AUF1 Restrains Hepatocyte Senescence by Maintaining Mitochondrial Homeostasis in AML12 Hepatocyte Model. | Cells | 2025 | https://conductscience.org/library/papers/41511332 | PubMed |
| 41321965 | Enhancing Osteogenesis in Dental Implants: ZNF710-AS1 and miR-146a-5p in Smad Signaling Pathway Activation. | Int J Mol Cell Med | 2025 | https://conductscience.org/library/papers/41321965 | PubMed |
| 40676394 | Unlocking temozolomide resistance in glioblastoma: the pivotal role of MicroRNAs and in-silico insights. | Med Oncol | 2025 | https://conductscience.org/library/papers/40676394 | PubMed |
| 39108857 | The roles of E2F7 in cancer: Current knowledge and future prospects. | Heliyon | 2024 | https://conductscience.org/library/papers/39108857 | PubMed |
| 38687607 | PL-hMSC and CH-hMSC derived soluble factors inhibit proliferation but improve hGBM cell migration by activating TGF-β and inhibiting Wnt signaling. | Biosci Rep | 2024 | https://conductscience.org/library/papers/38687607 | PubMed |
| 38345576 | ITGB2 fosters the cancerous characteristics of ovarian cancer cells through its role in mitochondrial glycolysis transformation. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38345576 | PubMed |
| 38292177 | Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting. | Genes Dis | 2024 | https://conductscience.org/library/papers/38292177 | PubMed |
| 37628949 | MiRNA-146a-A Key Player in Immunity and Diseases. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37628949 | PubMed |
| 37609424 | Long noncoding RNA HOXC-AS3 remodels lipid metabolism and promotes the proliferation of transformed macrophages in the glioma stem cell microenvironment by regulating the hnRNPA1/CaM axis. | Heliyon | 2023 | https://conductscience.org/library/papers/37609424 | PubMed |
| 37434173 | Prognostic risk factors of serous ovarian carcinoma based on mesenchymal stem cell phenotype and guidance for therapeutic efficacy. | J Transl Med | 2023 | https://conductscience.org/library/papers/37434173 | PubMed |
| 37385632 | Extracellular Vesicles Derived from Mesenchymal Stem Cells as Cell-Free Therapy for Intrauterine Adhesion. | Int J Stem Cells | 2023 | https://conductscience.org/library/papers/37385632 | PubMed |
| 37063077 | Upregulation of the ZNF148/PTX3 axis promotes malignant transformation of dendritic cells in glioma stem-like cells microenvironment. | CNS Neurosci Ther | 2023 | https://conductscience.org/library/papers/37063077 | PubMed |
| 36300592 | The peritumoral brain zone in glioblastoma: where we are and where we are going. | J Neurosci Res | 2023 | https://conductscience.org/library/papers/36300592 | PubMed |
| 35586206 | HOTAIRM1 Maintained the Malignant Phenotype of tMSCs Transformed by GSCs via E2F7 by Binding to FUS. | J Oncol | 2022 | https://conductscience.org/library/papers/35586206 | PubMed |
| 34612013 | Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas. | Cancer Med | 2021 | https://conductscience.org/library/papers/34612013 | PubMed |
| 34381770 | Time-Dependent Internalization of S100B by Mesenchymal Stem Cells via the Pathways of Clathrin- and Lipid Raft-Mediated Endocytosis. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34381770 | PubMed |
| 33902363 | S100A11 Promotes Glioma Cell Proliferation and Predicts Grade-Correlated Unfavorable Prognosis. | Technol Cancer Res Treat | 2021 | https://conductscience.org/library/papers/33902363 | PubMed |
| 33312949 | Single-Cell Sequencing of Glioblastoma Reveals Central Nervous System Susceptibility to SARS-CoV-2. | Front Oncol | 2020 | https://conductscience.org/library/papers/33312949 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32452829
GET https://conductscience.org/api/papers/v1/32452829/references?page=2